Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure

This publication has 26 references indexed in Scilit:

• Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure
  Published by Elsevier ,2010
• The effects of flosequinan on endothelin-1-induced changes in inositol 1,4,5-trisphosphate levels and protein kinase C activity in rat aorta
  European Journal of Pharmacology: Molecular Pharmacology, 1992
• Flosequinan: A vasodilator with positive inotropic activity
  American Heart Journal, 1991
• Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failure
  New England Journal of Medicine, 1987
• Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure
  American Heart Journal, 1987
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
  New England Journal of Medicine, 1986
• Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
  Circulation, 1984
• Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart Failure
  New England Journal of Medicine, 1982
• Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure
  Published by Elsevier ,1977
• Vasodilator Therapy for Heart Failure
  Circulation, 1973